Prelude Capital Management’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Prelude Capital Management’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-32,120	Closed	-$4.5M	–	2269
2020 Q3	$4.5M	Buy	+32,120	New	+$3.91M	0.22%	65
2020 Q1	–	Sell	-46	Closed	-$1K	–	2267
2019 Q4	$1K	Sell	46 -51	-53%	-$1.22K	﹤0.01%	1866
2019 Q3	$2K	Buy	+97	New	+$2.93K	﹤0.01%	1630

Prelude Capital Management's LVGO Position: Q4 2020 in Review

Prelude Capital Management sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 32,120 shares — an estimated $4.5M sold.

Prelude Capital Management first reported a position in LVGO in Q3 2019 and held it in 3 quarters. The position peaked at $4.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Prelude Capital Management reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Prelude Capital Management sold 32,120 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $4.5M.
Prelude Capital Management first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
Prelude Capital Management's Livongo Health, Inc. Common Stock position peaked at $4.5M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.